Xiaolei Zhang

5.8k total citations · 2 hit papers
150 papers, 4.2k citations indexed

About

Xiaolei Zhang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xiaolei Zhang has authored 150 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Molecular Biology, 44 papers in Oncology and 23 papers in Immunology. Recurrent topics in Xiaolei Zhang's work include Cytokine Signaling Pathways and Interactions (25 papers), PI3K/AKT/mTOR signaling in cancer (11 papers) and MicroRNA in disease regulation (10 papers). Xiaolei Zhang is often cited by papers focused on Cytokine Signaling Pathways and Interactions (25 papers), PI3K/AKT/mTOR signaling in cancer (11 papers) and MicroRNA in disease regulation (10 papers). Xiaolei Zhang collaborates with scholars based in China, United States and Macao. Xiaolei Zhang's co-authors include James Turkson, Peibin Yue, Patrick T. Gunning, Wei Zhao, Ziyou Lin, Steven Fletcher, Brent D. G. Page, Shumin Ouyang, David Paladino and Guohui Wan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Xiaolei Zhang

139 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RNA m ⁶ A methylation regulates sorafenib resistance in liver cancer through FOXO 3‐mediated autophagy

2020 359 citations Ziyou Lin, Yi Niu et al. The EMBO Journal profile →
Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer

2022 323 citations Shumin Ouyang, Zhenhua Zhang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaolei Zhang China	33	2.5k	1.4k	948	615	465	150	4.2k
Claudio Festuccia Italy	45	2.8k 1.1×	1.6k 1.2×	1.1k 1.1×	1.1k 1.8×	313 0.7×	164	5.3k
Yangfu Jiang China	31	2.7k 1.1×	1.1k 0.8×	1.2k 1.3×	456 0.7×	382 0.8×	70	4.9k
John Brognard United States	25	3.7k 1.5×	1.0k 0.7×	658 0.7×	464 0.8×	358 0.8×	50	4.5k
Meng Qiao China	33	2.0k 0.8×	1.6k 1.2×	863 0.9×	835 1.4×	252 0.5×	96	4.1k
Alexander T.H. Wu Taiwan	40	2.6k 1.0×	1.1k 0.8×	1.1k 1.2×	684 1.1×	320 0.7×	170	5.1k
Borhane Annabi Canada	41	2.2k 0.9×	1.1k 0.8×	1.2k 1.3×	324 0.5×	412 0.9×	151	4.8k
William H. Chappell United States	27	2.7k 1.1×	1.3k 0.9×	695 0.7×	418 0.7×	466 1.0×	41	4.0k
Jörg Bäsecke Germany	22	3.0k 1.2×	1.2k 0.8×	669 0.7×	338 0.5×	460 1.0×	34	4.4k
Peng Hou China	41	3.3k 1.3×	1.3k 0.9×	1.1k 1.2×	618 1.0×	546 1.2×	177	5.7k
Franca Stivala Italy	28	3.5k 1.4×	1.6k 1.1×	868 0.9×	514 0.8×	653 1.4×	58	5.4k

Countries citing papers authored by Xiaolei Zhang

Since Specialization

Citations

This map shows the geographic impact of Xiaolei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolei Zhang more than expected).

Fields of papers citing papers by Xiaolei Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolei Zhang. The network helps show where Xiaolei Zhang may publish in the future.

Co-authorship network of co-authors of Xiaolei Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolei Zhang. A scholar is included among the top collaborators of Xiaolei Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolei Zhang. Xiaolei Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ye, Zihan, Wei‐Bang Yu, Mu‐Yang Huang, et al.. (2025). Repurposing Cardiac Glycosides to Potentiate CD47 Blockade through Calreticulin‐mediated Phagocytic Effects for Lung Cancer Treatment. Advanced Science. 12(46). e08245–e08245.

Chen, Yuqing, et al.. (2025). Exploring the Link Between Diabetes, Herpes Zoster, and Post-Herpetic Neuralgia: Insights From Mendelian Randomization. Journal of Pain Research. Volume 18. 1479–1489.

Wang, Xiaochan, Yinyan Shi, Xiaolei Zhang, et al.. (2024). Keypoint detection and diameter estimation of cabbage (Brassica oleracea L.) heads under varying occlusion degrees via YOLOv8n-CK network. Computers and Electronics in Agriculture. 226. 109428–109428. 9 indexed citations

Tang, Zhenghai, et al.. (2024). Beyond cancer: The potential application of CD47-based therapy in non-cancer diseases. Acta Pharmaceutica Sinica B. 15(2). 757–791.

Zhang, Qiyi, Wen Ding, Jianshan Mo, et al.. (2024). Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma. Acta Pharmacologica Sinica. 45(8). 1701–1714. 8 indexed citations

Zhang, Xiaolei, et al.. (2024). Downregulation of microRNA‑221‑3p promotes angiogenesis of lipoprotein(a)‑injured endothelial progenitor cells by targeting silent information regulator 1 to activate the RAF/MEK/ERK signaling pathway. Molecular Medicine Reports. 30(6). 1 indexed citations

Zhang, Xiaolei, Min Li, Xudong Chen, et al.. (2023). Intelligent Ti3C2–Pt heterojunction with oxygen self-supply for augmented chemo-sonodynamic/immune tumor therapy. Materials Today Nano. 24. 100386–100386. 5 indexed citations

Lin, Ziyou, Jian Zhang, Weineng Feng, et al.. (2023). Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non–Small Cell Lung Cancer. Cancer Research. 83(13). 2187–2207. 75 indexed citations

Cao, Shuhua, et al.. (2023). A novel tetranuclear Cu(ii) complex for DNA-binding and in vitro anticancer activity. RSC Advances. 13(38). 26324–26329. 4 indexed citations

10.

Wang, Yao, Yanchun Wang, Jun Ma, et al.. (2023). Effects of electroacupuncture on the intestinal thioredoxin interaction protein/Nod-like receptor 3 signaling pathway in mice with Parkinson's disease.. PubMed. 48(10). 1041–1047.

11.

Liu, Jie, et al.. (2022). Trends in anti-HER2 drugs consumption and influencing factors. Frontiers in Public Health. 10. 944071–944071. 6 indexed citations

12.

Lin, Ziyou, Arabella Wan, Lei Sun, et al.. (2022). N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis. Molecular Therapy. 31(2). 517–534. 56 indexed citations

13.

Lin, Ziyou, Yi Niu, Arabella Wan, et al.. (2020). RNA m ⁶ A methylation regulates sorafenib resistance in liver cancer through FOXO 3‐mediated autophagy. The EMBO Journal. 39(12). e103181–e103181. 359 indexed citations breakdown →

14.

Zheng, Jianwei, Junfeng Wang, Junfeng Wang, et al.. (2020). Targeting castration-resistant prostate cancer with a novel RORγ antagonist elaiophylin. Acta Pharmaceutica Sinica B. 10(12). 2313–2322. 26 indexed citations

15.

Zhang, Xiaolei, Feng Wang, Zijie Wang, et al.. (2020). ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner. Annals of Translational Medicine. 8(10). 646–646. 60 indexed citations

16.

Huang, Xiao‐Jun, Xiaolei Zhang, Xin Zhou, et al.. (2020). Prevalence of Thyroid Dysfunction in a Chinese Population with Different Glucose Intolerance Status: A Community-Based Cross-Sectional Study. SHILAP Revista de lepidopterología. 1 indexed citations

17.

Peng, Lihong, Yongye Liang, Xiaorong Zhong, et al.. (2020). Aptamer-Conjugated Gold Nanoparticles Targeting Epidermal Growth Factor Receptor Variant III for the Treatment of Glioblastoma. SHILAP Revista de lepidopterología.

18.

Zhang, Xiaolei, Xia Zhao, Jittima Amie Luckanagul, et al.. (2017). Polymer–Protein Core–Shell Nanoparticles for Enhanced Antigen Immunogenicity. ACS Macro Letters. 6(4). 442–446. 17 indexed citations

19.

Zhang, Xiaolei, Ying Sun, Roberta Pireddu, et al.. (2013). A Novel Inhibitor of STAT3 Homodimerization Selectively Suppresses STAT3 Activity and Malignant Transformation. Cancer Research. 73(6). 1922–1933. 122 indexed citations

20.

Fletcher, Steven, Xiaolei Zhang, Peibin Yue, et al.. (2009). Disruption of Transcriptionally Active Stat3 Dimers with Non‐phosphorylated, Salicylic Acid‐Based Small Molecules: Potent in vitro and Tumor Cell Activities. ChemBioChem. 10(12). 1959–1964. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact